This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nørrelund, H. Articles by Jørgensen, J. O. L. Search for Related Content PubMed PubMed Citation Articles by Nørrelund, H. Articles by Jørgensen, J. O. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-PHENYLALANINE GLYCERIN HYDROCORTISONE LIOTHYRONINE UREA

Continuation of Growth Hormone (GH) Substitution during Fasting in GH-Deficient Patients Decreases Urea Excretion and Conserves Protein Synthesis¹

Medical Department M (Endocrinology and Diabetes) (H.N., N.M., J.S.C., J.O.L.J.), Aarhus Kommunehospital, Aarhus DK-8000, Denmark; and Endocrinology Division (K.S.N.), Mayo Clinic, Rochester, Minnesota 55905

Address all correspondence and requests for reprints to: Helene Nørrelund, Medical Department M, Aarhus Kommunehospital, 8000 Aarhus C, Denmark. E-mail: helenenorrelund{at}dadlnet.dk

Abstract

The consequences of GH deficiency during conditions in which endogenous GH release is acutely stimulated are largely unknown. Short-term fasting constitutes a robust GH stimulus, but the metabolic significance of GH during fasting is uncertain.

To address both of these issues, we therefore evaluated the effect of GH on substrate metabolism during fasting in adults with GH deficiency. Seven hypopituitary GH-deficient patients were each studied twice during a 40-h fast: once with GH replacement continued and once with GH discontinued during the fast. After 40 h of fasting, protein synthesis and turnover were higher with than without GH replacement [phenylalanine incorporation (µmol/kg fat free mass/h): 36.6 ± 1.2 (GH) vs. 32.8 ± 1.4, P < 0.05; phenylalanine flux (µmol/kg fat free mass/h): 41.3 ± 1.0 (GH) vs. 38.0 ± 1.8, P < 0.05]. During continued GH replacement, urea excretion decreased during nighttime [urea excretion (mmol/24 h): 269 ± 51 (GH) vs. 390 ± 69, P < 0.05], and a significant decline in urea-N synthesis rate was found [urea-N synthesis rate (mmol/h): 14.7 ± 1.6 (GH) vs. 21.1 ± 2.2, P < 0.01]. GH replacement was associated with increased lipid oxidation [lipid oxidation (mg/kg per min): 0.91 ± 0.07 (GH) vs. 0.70 ± 0.03, P < 0.05]. Finally, continuation of GH induced moderate elevations in plasma glucose levels without significant changes in total glucose turnover or oxidation.

In summary, continued GH substitution during fasting conserves nitrogen, which involves stimulation or maintenance of protein synthesis. Our data support the importance of GH replacement in hypopituitary adults.

This article has been cited by other articles:

				H. Norrelund, C. Djurhuus, J. O. L. Jorgensen, S. Nielsen, K. S. Nair, O. Schmitz, J. S. Christiansen, and N. Moller Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E737 - E743. [Abstract] [Full Text] [PDF]

				H. Norrelund, K. S. Nair, S. Nielsen, J. Frystyk, P. Ivarsen, J. O. L. Jorgensen, J. S. Christiansen, and N. Moller The Decisive Role of Free Fatty Acids for Protein Conservation during Fasting in Humans with and without Growth Hormone J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4371 - 4378. [Abstract] [Full Text] [PDF]